カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のIPVワクチン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global IPV Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19436）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19436
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：90
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のIPVワクチン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

IPVワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のIPVワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

IPVワクチン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・マホニー、MEF1、ソーケット

用途別セグメントは次のように区分されます。
・民間流通経路、公共流通経路

世界のIPVワクチン市場の主要な市場プレーヤーは以下のとおりです。
・GlaxoSmithKline Plc、Sanofi S.A、Serum Institute of India Pvt. Ltd.、PT Bio Farma、AJ Vaccines

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、IPVワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なIPVワクチンメーカーの企業概要、2019年～2022年までのIPVワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なIPVワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別IPVワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのIPVワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのIPVワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびIPVワクチンの産業チェーンを掲載しています。
・第13、14、15章では、IPVワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- IPVワクチンの概要
- 種類別分析（2017年vs2021年vs2028年）：マホニー、MEF1、ソーケット
- 用途別分析（2017年vs2021年vs2028年）：民間流通経路、公共流通経路
- 世界のIPVワクチン市場規模・予測
- 世界のIPVワクチン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- GlaxoSmithKline Plc、Sanofi S.A、Serum Institute of India Pvt. Ltd.、PT Bio Farma、AJ Vaccines
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：マホニー、MEF1、ソーケット
・用途別分析2017年-2028年：民間流通経路、公共流通経路
・IPVワクチンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・IPVワクチンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・IPVワクチンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・IPVワクチンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・IPVワクチンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The IPV Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global IPV Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Private Distribution Channel accounting for % of the IPV Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Mahoney segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of IPV Vaccine include GlaxoSmithKline Plc, Sanofi S.A, Serum Institute of India Pvt. Ltd., PT Bio Farma, and AJ Vaccines, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
IPV Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Mahoney
MEF1
Saukett
Market segment by Application can be divided into
Private Distribution Channel
Public Distribution Channel
The key market players for global IPV Vaccine market are listed below:
GlaxoSmithKline Plc
Sanofi S.A
Serum Institute of India Pvt. Ltd.
PT Bio Farma
AJ Vaccines
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe IPV Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of IPV Vaccine, with price, sales, revenue and global market share of IPV Vaccine from 2019 to 2022.
Chapter 3, the IPV Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the IPV Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and IPV Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of IPV Vaccine.
Chapter 13, 14, and 15, to describe IPV Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 IPV Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global IPV Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Mahoney
1.2.3 MEF1
1.2.4 Saukett
1.3 Market Analysis by Application
1.3.1 Overview: Global IPV Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Private Distribution Channel
1.3.3 Public Distribution Channel
1.4 Global IPV Vaccine Market Size & Forecast
1.4.1 Global IPV Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global IPV Vaccine Sales in Volume (2017-2028)
1.4.3 Global IPV Vaccine Price (2017-2028)
1.5 Global IPV Vaccine Production Capacity Analysis
1.5.1 Global IPV Vaccine Total Production Capacity (2017-2028)
1.5.2 Global IPV Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 IPV Vaccine Market Drivers
1.6.2 IPV Vaccine Market Restraints
1.6.3 IPV Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline Plc
2.1.1 GlaxoSmithKline Plc Details
2.1.2 GlaxoSmithKline Plc Major Business
2.1.3 GlaxoSmithKline Plc IPV Vaccine Product and Services
2.1.4 GlaxoSmithKline Plc IPV Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi S.A
2.2.1 Sanofi S.A Details
2.2.2 Sanofi S.A Major Business
2.2.3 Sanofi S.A IPV Vaccine Product and Services
2.2.4 Sanofi S.A IPV Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Serum Institute of India Pvt. Ltd.
2.3.1 Serum Institute of India Pvt. Ltd. Details
2.3.2 Serum Institute of India Pvt. Ltd. Major Business
2.3.3 Serum Institute of India Pvt. Ltd. IPV Vaccine Product and Services
2.3.4 Serum Institute of India Pvt. Ltd. IPV Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 PT Bio Farma
2.4.1 PT Bio Farma Details
2.4.2 PT Bio Farma Major Business
2.4.3 PT Bio Farma IPV Vaccine Product and Services
2.4.4 PT Bio Farma IPV Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 AJ Vaccines
2.5.1 AJ Vaccines Details
2.5.2 AJ Vaccines Major Business
2.5.3 AJ Vaccines IPV Vaccine Product and Services
2.5.4 AJ Vaccines IPV Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 IPV Vaccine Breakdown Data by Manufacturer
3.1 Global IPV Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global IPV Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in IPV Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 IPV Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 IPV Vaccine Manufacturer Market Share in 2021
3.5 Global IPV Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and IPV Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global IPV Vaccine Market Size by Region
4.1.1 Global IPV Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global IPV Vaccine Revenue by Region (2017-2028)
4.2 North America IPV Vaccine Revenue (2017-2028)
4.3 Europe IPV Vaccine Revenue (2017-2028)
4.4 Asia-Pacific IPV Vaccine Revenue (2017-2028)
4.5 South America IPV Vaccine Revenue (2017-2028)
4.6 Middle East and Africa IPV Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global IPV Vaccine Sales in Volume by Type (2017-2028)
5.2 Global IPV Vaccine Revenue by Type (2017-2028)
5.3 Global IPV Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global IPV Vaccine Sales in Volume by Application (2017-2028)
6.2 Global IPV Vaccine Revenue by Application (2017-2028)
6.3 Global IPV Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America IPV Vaccine Sales by Type (2017-2028)
7.2 North America IPV Vaccine Sales by Application (2017-2028)
7.3 North America IPV Vaccine Market Size by Country
7.3.1 North America IPV Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America IPV Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe IPV Vaccine Sales by Type (2017-2028)
8.2 Europe IPV Vaccine Sales by Application (2017-2028)
8.3 Europe IPV Vaccine Market Size by Country
8.3.1 Europe IPV Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe IPV Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific IPV Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific IPV Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific IPV Vaccine Market Size by Region
9.3.1 Asia-Pacific IPV Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific IPV Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America IPV Vaccine Sales by Type (2017-2028)
10.2 South America IPV Vaccine Sales by Application (2017-2028)
10.3 South America IPV Vaccine Market Size by Country
10.3.1 South America IPV Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America IPV Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa IPV Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa IPV Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa IPV Vaccine Market Size by Country
11.3.1 Middle East & Africa IPV Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa IPV Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of IPV Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of IPV Vaccine
12.3 IPV Vaccine Production Process
12.4 IPV Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 IPV Vaccine Typical Distributors
13.3 IPV Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global IPV Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global IPV Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Plc Major Business
Table 5. GlaxoSmithKline Plc IPV Vaccine Product and Services
Table 6. GlaxoSmithKline Plc IPV Vaccine Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Sanofi S.A Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi S.A Major Business
Table 9. Sanofi S.A IPV Vaccine Product and Services
Table 10. Sanofi S.A IPV Vaccine Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 12. Serum Institute of India Pvt. Ltd. Major Business
Table 13. Serum Institute of India Pvt. Ltd. IPV Vaccine Product and Services
Table 14. Serum Institute of India Pvt. Ltd. IPV Vaccine Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. PT Bio Farma Basic Information, Manufacturing Base and Competitors
Table 16. PT Bio Farma Major Business
Table 17. PT Bio Farma IPV Vaccine Product and Services
Table 18. PT Bio Farma IPV Vaccine Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. AJ Vaccines Basic Information, Manufacturing Base and Competitors
Table 20. AJ Vaccines Major Business
Table 21. AJ Vaccines IPV Vaccine Product and Services
Table 22. AJ Vaccines IPV Vaccine Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global IPV Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Units)
Table 24. Global IPV Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in IPV Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global IPV Vaccine Production Capacity by Company, (Units): 2020 VS 2021
Table 27. Head Office and IPV Vaccine Production Site of Key Manufacturer
Table 28. IPV Vaccine New Entrant and Capacity Expansion Plans
Table 29. IPV Vaccine Mergers & Acquisitions in the Past Five Years
Table 30. Global IPV Vaccine Sales by Region (2017-2022) & (Units)
Table 31. Global IPV Vaccine Sales by Region (2023-2028) & (Units)
Table 32. Global IPV Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 33. Global IPV Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 34. Global IPV Vaccine Sales by Type (2017-2022) & (Units)
Table 35. Global IPV Vaccine Sales by Type (2023-2028) & (Units)
Table 36. Global IPV Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 37. Global IPV Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 38. Global IPV Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 39. Global IPV Vaccine Price by Type (2023-2028) & (US$/Unit)
Table 40. Global IPV Vaccine Sales by Application (2017-2022) & (Units)
Table 41. Global IPV Vaccine Sales by Application (2023-2028) & (Units)
Table 42. Global IPV Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 43. Global IPV Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 44. Global IPV Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 45. Global IPV Vaccine Price by Application (2023-2028) & (US$/Unit)
Table 46. North America IPV Vaccine Sales by Country (2017-2022) & (Units)
Table 47. North America IPV Vaccine Sales by Country (2023-2028) & (Units)
Table 48. North America IPV Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 49. North America IPV Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 50. North America IPV Vaccine Sales by Type (2017-2022) & (Units)
Table 51. North America IPV Vaccine Sales by Type (2023-2028) & (Units)
Table 52. North America IPV Vaccine Sales by Application (2017-2022) & (Units)
Table 53. North America IPV Vaccine Sales by Application (2023-2028) & (Units)
Table 54. Europe IPV Vaccine Sales by Country (2017-2022) & (Units)
Table 55. Europe IPV Vaccine Sales by Country (2023-2028) & (Units)
Table 56. Europe IPV Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe IPV Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe IPV Vaccine Sales by Type (2017-2022) & (Units)
Table 59. Europe IPV Vaccine Sales by Type (2023-2028) & (Units)
Table 60. Europe IPV Vaccine Sales by Application (2017-2022) & (Units)
Table 61. Europe IPV Vaccine Sales by Application (2023-2028) & (Units)
Table 62. Asia-Pacific IPV Vaccine Sales by Region (2017-2022) & (Units)
Table 63. Asia-Pacific IPV Vaccine Sales by Region (2023-2028) & (Units)
Table 64. Asia-Pacific IPV Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific IPV Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific IPV Vaccine Sales by Type (2017-2022) & (Units)
Table 67. Asia-Pacific IPV Vaccine Sales by Type (2023-2028) & (Units)
Table 68. Asia-Pacific IPV Vaccine Sales by Application (2017-2022) & (Units)
Table 69. Asia-Pacific IPV Vaccine Sales by Application (2023-2028) & (Units)
Table 70. South America IPV Vaccine Sales by Country (2017-2022) & (Units)
Table 71. South America IPV Vaccine Sales by Country (2023-2028) & (Units)
Table 72. South America IPV Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 73. South America IPV Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 74. South America IPV Vaccine Sales by Type (2017-2022) & (Units)
Table 75. South America IPV Vaccine Sales by Type (2023-2028) & (Units)
Table 76. South America IPV Vaccine Sales by Application (2017-2022) & (Units)
Table 77. South America IPV Vaccine Sales by Application (2023-2028) & (Units)
Table 78. Middle East & Africa IPV Vaccine Sales by Region (2017-2022) & (Units)
Table 79. Middle East & Africa IPV Vaccine Sales by Region (2023-2028) & (Units)
Table 80. Middle East & Africa IPV Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa IPV Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa IPV Vaccine Sales by Type (2017-2022) & (Units)
Table 83. Middle East & Africa IPV Vaccine Sales by Type (2023-2028) & (Units)
Table 84. Middle East & Africa IPV Vaccine Sales by Application (2017-2022) & (Units)
Table 85. Middle East & Africa IPV Vaccine Sales by Application (2023-2028) & (Units)
Table 86. IPV Vaccine Raw Material
Table 87. Key Manufacturers of IPV Vaccine Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. IPV Vaccine Typical Distributors
Table 91. IPV Vaccine Typical Customers
List of Figures
Figure 1. IPV Vaccine Picture
Figure 2. Global IPV Vaccine Revenue Market Share by Type in 2021
Figure 3. Mahoney
Figure 4. MEF1
Figure 5. Saukett
Figure 6. Global IPV Vaccine Revenue Market Share by Application in 2021
Figure 7. Private Distribution Channel
Figure 8. Public Distribution Channel
Figure 9. Global IPV Vaccine Revenue, (USD Million) & (Units): 2017 & 2021 & 2028
Figure 10. Global IPV Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global IPV Vaccine Sales (2017-2028) & (Units)
Figure 12. Global IPV Vaccine Price (2017-2028) & (US$/Unit)
Figure 13. Global IPV Vaccine Production Capacity (2017-2028) & (Units)
Figure 14. Global IPV Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. IPV Vaccine Market Drivers
Figure 16. IPV Vaccine Market Restraints
Figure 17. IPV Vaccine Market Trends
Figure 18. Global IPV Vaccine Sales Market Share by Manufacturer in 2021
Figure 19. Global IPV Vaccine Revenue Market Share by Manufacturer in 2021
Figure 20. IPV Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 IPV Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 IPV Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 23. Global IPV Vaccine Sales Market Share by Region (2017-2028)
Figure 24. Global IPV Vaccine Revenue Market Share by Region (2017-2028)
Figure 25. North America IPV Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Europe IPV Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific IPV Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. South America IPV Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa IPV Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Global IPV Vaccine Sales Market Share by Type (2017-2028)
Figure 31. Global IPV Vaccine Revenue Market Share by Type (2017-2028)
Figure 32. Global IPV Vaccine Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global IPV Vaccine Sales Market Share by Application (2017-2028)
Figure 34. Global IPV Vaccine Revenue Market Share by Application (2017-2028)
Figure 35. Global IPV Vaccine Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America IPV Vaccine Sales Market Share by Type (2017-2028)
Figure 37. North America IPV Vaccine Sales Market Share by Application (2017-2028)
Figure 38. North America IPV Vaccine Sales Market Share by Country (2017-2028)
Figure 39. North America IPV Vaccine Revenue Market Share by Country (2017-2028)
Figure 40. United States IPV Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada IPV Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico IPV Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe IPV Vaccine Sales Market Share by Type (2017-2028)
Figure 44. Europe IPV Vaccine Sales Market Share by Application (2017-2028)
Figure 45. Europe IPV Vaccine Sales Market Share by Country (2017-2028)
Figure 46. Europe IPV Vaccine Revenue Market Share by Country (2017-2028)
Figure 47. Germany IPV Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France IPV Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom IPV Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia IPV Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy IPV Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific IPV Vaccine Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific IPV Vaccine Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific IPV Vaccine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific IPV Vaccine Revenue Market Share by Region (2017-2028)
Figure 56. China IPV Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan IPV Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea IPV Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India IPV Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia IPV Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia IPV Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America IPV Vaccine Sales Market Share by Type (2017-2028)
Figure 63. South America IPV Vaccine Sales Market Share by Application (2017-2028)
Figure 64. South America IPV Vaccine Sales Market Share by Country (2017-2028)
Figure 65. South America IPV Vaccine Revenue Market Share by Country (2017-2028)
Figure 66. Brazil IPV Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina IPV Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa IPV Vaccine Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa IPV Vaccine Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa IPV Vaccine Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa IPV Vaccine Revenue Market Share by Region (2017-2028)
Figure 72. Turkey IPV Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt IPV Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia IPV Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa IPV Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of IPV Vaccine in 2021
Figure 77. Manufacturing Process Analysis of IPV Vaccine
Figure 78. IPV Vaccine Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のA型肝炎及びB型肝炎用混合ワクチン市場2022年：市場規模予測（～2028年）
  • 世界の肺炎球菌ワクチン多価市場2022年：市場規模予測（～2028年）
  • アジュバント使用インフルエンザワクチンのグローバル市場展望 2023年-2029年：バイアル、充填済み
  • 世界の獣医用ウイルスベクター化ワクチン市場2022年：市場規模予測（～2028年）
  • 卵不使用インフルエンザワクチンのグローバル市場展望 2023年-2029年：細胞培養インフルエンザワクチン、組換えインフルエンザワクチン
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19436 )"世界のIPVワクチン市場2022年：市場規模予測（～2028年）" (英文：Global IPV Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。